Cargando…
High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13
We have combined random 6 amino acid substrate phage display with high throughput sequencing to comprehensively define the active site specificity of the serine protease thrombin and the metalloprotease ADAMTS13. The substrate motif for thrombin was determined by >6,700 cleaved peptides, and was...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809430/ https://www.ncbi.nlm.nih.gov/pubmed/29434246 http://dx.doi.org/10.1038/s41598-018-21021-9 |
_version_ | 1783299556643962880 |
---|---|
author | Kretz, Colin A. Tomberg, Kärt Van Esbroeck, Alexander Yee, Andrew Ginsburg, David |
author_facet | Kretz, Colin A. Tomberg, Kärt Van Esbroeck, Alexander Yee, Andrew Ginsburg, David |
author_sort | Kretz, Colin A. |
collection | PubMed |
description | We have combined random 6 amino acid substrate phage display with high throughput sequencing to comprehensively define the active site specificity of the serine protease thrombin and the metalloprotease ADAMTS13. The substrate motif for thrombin was determined by >6,700 cleaved peptides, and was highly concordant with previous studies. In contrast, ADAMTS13 cleaved only 96 peptides (out of >10(7) sequences), with no apparent consensus motif. However, when the hexapeptide library was substituted into the P3-P3′ interval of VWF73, an exosite-engaging substrate of ADAMTS13, 1670 unique peptides were cleaved. ADAMTS13 exhibited a general preference for aliphatic amino acids throughout the P3-P3′ interval, except at P2 where Arg was tolerated. The cleaved peptides assembled into a motif dominated by P3 Leu, and bulky aliphatic residues at P1 and P1′. Overall, the P3-P2′ amino acid sequence of von Willebrand Factor appears optimally evolved for ADAMTS13 recognition. These data confirm the critical role of exosite engagement for substrates to gain access to the active site of ADAMTS13, and define the substrate recognition motif for ADAMTS13. Combining substrate phage display with high throughput sequencing is a powerful approach for comprehensively defining the active site specificity of proteases. |
format | Online Article Text |
id | pubmed-5809430 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-58094302018-02-15 High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13 Kretz, Colin A. Tomberg, Kärt Van Esbroeck, Alexander Yee, Andrew Ginsburg, David Sci Rep Article We have combined random 6 amino acid substrate phage display with high throughput sequencing to comprehensively define the active site specificity of the serine protease thrombin and the metalloprotease ADAMTS13. The substrate motif for thrombin was determined by >6,700 cleaved peptides, and was highly concordant with previous studies. In contrast, ADAMTS13 cleaved only 96 peptides (out of >10(7) sequences), with no apparent consensus motif. However, when the hexapeptide library was substituted into the P3-P3′ interval of VWF73, an exosite-engaging substrate of ADAMTS13, 1670 unique peptides were cleaved. ADAMTS13 exhibited a general preference for aliphatic amino acids throughout the P3-P3′ interval, except at P2 where Arg was tolerated. The cleaved peptides assembled into a motif dominated by P3 Leu, and bulky aliphatic residues at P1 and P1′. Overall, the P3-P2′ amino acid sequence of von Willebrand Factor appears optimally evolved for ADAMTS13 recognition. These data confirm the critical role of exosite engagement for substrates to gain access to the active site of ADAMTS13, and define the substrate recognition motif for ADAMTS13. Combining substrate phage display with high throughput sequencing is a powerful approach for comprehensively defining the active site specificity of proteases. Nature Publishing Group UK 2018-02-12 /pmc/articles/PMC5809430/ /pubmed/29434246 http://dx.doi.org/10.1038/s41598-018-21021-9 Text en © The Author(s) 2018 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Kretz, Colin A. Tomberg, Kärt Van Esbroeck, Alexander Yee, Andrew Ginsburg, David High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13 |
title | High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13 |
title_full | High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13 |
title_fullStr | High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13 |
title_full_unstemmed | High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13 |
title_short | High throughput protease profiling comprehensively defines active site specificity for thrombin and ADAMTS13 |
title_sort | high throughput protease profiling comprehensively defines active site specificity for thrombin and adamts13 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5809430/ https://www.ncbi.nlm.nih.gov/pubmed/29434246 http://dx.doi.org/10.1038/s41598-018-21021-9 |
work_keys_str_mv | AT kretzcolina highthroughputproteaseprofilingcomprehensivelydefinesactivesitespecificityforthrombinandadamts13 AT tombergkart highthroughputproteaseprofilingcomprehensivelydefinesactivesitespecificityforthrombinandadamts13 AT vanesbroeckalexander highthroughputproteaseprofilingcomprehensivelydefinesactivesitespecificityforthrombinandadamts13 AT yeeandrew highthroughputproteaseprofilingcomprehensivelydefinesactivesitespecificityforthrombinandadamts13 AT ginsburgdavid highthroughputproteaseprofilingcomprehensivelydefinesactivesitespecificityforthrombinandadamts13 |